It is worth noting that one drug targeting STAT3 that is in clinical development, ochromycinone (STA-21)26, can attenuate the anemic phenotype in our zebrafish DBA model (Fig. S12). This evidence concerns the gene STAT3 and Diamond-Blackfan anemia.